FDA To Work With Emergent BioSolutions To Ensure Vaccine Quality
FDA To Work With Emergent BioSolutions To Ensure Vaccine Quality

The FDA has not yet authorized Emergent to manufacture or distribute and Johnson & Johnson COVID-19 vaccines or components to date.

They also recently asked the facility to pause any manufacturing while they completed their investigation.